Global health R&D at work in Georgia
Emory University School of Medicine is supporting early stage clinical trials of a vaccine to prevent infection with chikungunya virus. Chikungunya is transmitted by mosquitoes and can cause persistent, debilitating joint pain. The virus, originating in Africa, arrived in the Caribbean several years ago and has since infected more than 2 million people in the Americas, including in the Florida Keys. If approved, the vaccine could be a powerful tool for protection.